How it went for everyone who tried it
Helped means they said it helped with what they took it for, which may be one symptom and not the illness.
Shares are out of the 14 people who said how it went. 2 more tried it without saying how it went.
| How it went | People | Share |
|---|---|---|
| Helped a lot | 4 | 29% |
| Helped | 4 | 28% |
| No change | 3 | 22% |
| Worse | 3 | 21% |
| Much worse | 0 | 0% |
Shares are rounded to add up to 100, so two equal counts can show a point apart.
| Where it was reported | Helped | Said how it went |
|---|---|---|
| 6 | 11 | |
| Recovery stories | 2 | 3 |
Did it last, for everyone it helped?
- It wore off for 4 of the 8 people it helped: 3 who credit it for their improvement, 1 who doesn’t.
How it went for everyone who tried it
Helped means they said it helped with what they took it for, which may be one symptom and not the illness.
Shares are out of the 6 people who said how it went. 1 more tried it without saying how it went.
| How it went | People | Share |
|---|---|---|
| Helped a lot | 1 | 17% |
| Helped | 1 | 17% |
| No change | 2 | 33% |
| Worse | 2 | 33% |
| Much worse | 0 | 0% |
How it went for everyone who tried it
Helped means they said it helped with what they took it for, which may be one symptom and not the illness.
Shares are out of the 8 people who said how it went. 1 more tried it without saying how it went.
| How it went | People | Share |
|---|---|---|
| Helped a lot | 3 | 38% |
| Helped | 3 | 37% |
| No change | 1 | 13% |
| Worse | 1 | 12% |
| Much worse | 0 | 0% |
Shares are rounded to add up to 100, so two equal counts can show a point apart.
| Where it was reported | Helped | Said how it went |
|---|---|---|
| 4 | 5 | |
| Recovery stories | 2 | 3 |
Did it last, for everyone it helped?
- It wore off for 3 of the 6 people it helped: 2 who credit it for their improvement, 1 who doesn’t.
Ask about this treatment
Among the 7 who credit it with their improvement, here’s how they are now
Credit it means they say it’s one reason they got better: 3 say it helped them most; 4 say it was one of several things that helped.
Where each person was at the end of their story, or in their latest post that says how they are, compared with their worst point.
| Outcome described | People | Share |
|---|---|---|
| Recovered | 0 | 0% |
| Near normal | 1 | 14% |
| Much better | 4 | 57% |
| Somewhat better | 0 | 0% |
| Relapsed | 2 | 29% |
Did it last?
- 3 of the 7 who credit it said its benefit wore off (1 of them among the 2 who relapsed).
- 3 of the 7 who credit it say they still need to keep doing something (not always this) to stay well.
Among the 2 who credit it with their improvement, here’s how they are now
Credit it means they say it’s one reason they got better: 2 say it was one of several things that helped.
Where each person was at the end of their story, or in their latest post that says how they are, compared with their worst point.
| Outcome described | People | Share |
|---|---|---|
| Recovered | 0 | 0% |
| Near normal | 1 | 50% |
| Much better | 1 | 50% |
| Somewhat better | 0 | 0% |
| Relapsed | 0 | 0% |
Did it last?
- 1 of the 2 who credit it said its benefit wore off.
- 2 of the 2 who credit it say they still need to keep doing something (not always this) to stay well.
Among the 5 who credit it with their improvement, here’s how they are now
Credit it means they say it’s one reason they got better: 3 say it helped them most; 2 say it was one of several things that helped.
Where each person was at the end of their story, or in their latest post that says how they are, compared with their worst point.
| Outcome described | People | Share |
|---|---|---|
| Recovered | 0 | 0% |
| Near normal | 0 | 0% |
| Much better | 3 | 60% |
| Somewhat better | 0 | 0% |
| Relapsed | 2 | 40% |
Did it last?
- 2 of the 5 who credit it said its benefit wore off (1 of them among the 2 who relapsed).
- 1 of the 5 who credit it says they still need to keep doing something (not always this) to stay well.
Everyone · not split by condition
By how ill people were
Only the 7 who credit it, so people it didn’t help or made worse aren’t here. How they are now is their outcome overall, not the effect of this one treatment.
| Severity at worst | How they are now | n | Recovered or near normal |
|---|---|---|---|
| Mild | 1 | 100%, few people | |
| Moderate | 1 | 0%, few people | |
| Severe | 2 | 0%, few people | |
| Very severe | 2 | 0%, few people | |
| Not stated | 1 | 0%, few people |
| At worst | Outcome | People | Share |
|---|---|---|---|
| Mild | Near normal | 1 of 1 | 100% |
| Moderate | Much better | 1 of 1 | 100% |
| Severe | Much better | 1 of 2 | 50% |
| Severe | Relapsed | 1 of 2 | 50% |
| Very severe | Much better | 2 of 2 | 100% |
| Not stated | Relapsed | 1 of 1 | 100% |
Everyone · not split by condition
What people started next
6 of the 14 people who said how it went saw no change or got worse. 4 of those 6 say what they started next.
Everyone · not split by condition
Adverse events
What people said went wrong, in their own words.
4 of 16
people who wrote about taking it described a problem they tied to it
By kind
Unpleasant effects people tied to it, the most serious first.
Made symptoms worse · 1Side effects · 4 Show all 2Hide
Made symptoms worse
1 person“I started the jak stat afterwards, which progressively made me feel worse day by day over the 10 days I took it.”
— Falcon 58277 Side effects
4 people“I even had one day where I woke up and my brain felt drunk, like I had had too much to drink.”
— Falcon 58277 “I tried Tolacitinib but I dont know why my body reacted so bad.”
— Gull 82171
All posts · not split by condition
How often it comes up
Posts that mention Tofacitinib (Xeljanz), per 1,000 posts each month. Hover or tap a point for the count.
| Month | Posts mentioning it | All posts | Per 1,000 |
|---|---|---|---|
| Oct 2009 | 0 | 105 | 0 |
| Jan 2010 | 0 | 141 | 0 |
| Feb 2010 | 0 | 113 | 0 |
| Jun 2011 | 0 | 109 | 0 |
| Nov 2011 | 0 | 124 | 0 |
| Dec 2011 | 0 | 199 | 0 |
| Jan 2012 | 0 | 232 | 0 |
| Feb 2012 | 0 | 103 | 0 |
| Mar 2012 | 0 | 190 | 0 |
| Apr 2012 | 0 | 162 | 0 |
| May 2012 | 0 | 375 | 0 |
| Jun 2012 | 0 | 238 | 0 |
| Jul 2012 | 0 | 240 | 0 |
| Aug 2012 | 0 | 485 | 0 |
| Sep 2012 | 0 | 561 | 0 |
| Oct 2012 | 0 | 526 | 0 |
| Nov 2012 | 0 | 514 | 0 |
| Dec 2012 | 0 | 699 | 0 |
| Jan 2013 | 0 | 533 | 0 |
| Feb 2013 | 0 | 447 | 0 |
| Mar 2013 | 0 | 429 | 0 |
| Apr 2013 | 0 | 499 | 0 |
| May 2013 | 0 | 606 | 0 |
| Jun 2013 | 0 | 609 | 0 |
| Jul 2013 | 0 | 616 | 0 |
| Aug 2013 | 0 | 577 | 0 |
| Sep 2013 | 0 | 364 | 0 |
| Oct 2013 | 0 | 536 | 0 |
| Nov 2013 | 0 | 385 | 0 |
| Dec 2013 | 0 | 519 | 0 |
| Jan 2014 | 0 | 944 | 0 |
| Feb 2014 | 0 | 821 | 0 |
| Mar 2014 | 0 | 425 | 0 |
| Apr 2014 | 0 | 361 | 0 |
| May 2014 | 0 | 617 | 0 |
| Jun 2014 | 0 | 489 | 0 |
| Jul 2014 | 0 | 444 | 0 |
| Aug 2014 | 0 | 622 | 0 |
| Sep 2014 | 0 | 507 | 0 |
| Oct 2014 | 0 | 678 | 0 |
| Nov 2014 | 0 | 567 | 0 |
| Dec 2014 | 0 | 629 | 0 |
| Jan 2015 | 0 | 760 | 0 |
| Feb 2015 | 0 | 873 | 0 |
| Mar 2015 | 0 | 1,276 | 0 |
| Apr 2015 | 0 | 984 | 0 |
| May 2015 | 0 | 1,496 | 0 |
| Jun 2015 | 0 | 1,046 | 0 |
| Jul 2015 | 0 | 1,211 | 0 |
| Aug 2015 | 0 | 998 | 0 |
| Sep 2015 | 0 | 1,060 | 0 |
| Oct 2015 | 0 | 1,255 | 0 |
| Nov 2015 | 0 | 1,246 | 0 |
| Dec 2015 | 0 | 924 | 0 |
| Jan 2016 | 0 | 1,282 | 0 |
| Feb 2016 | 0 | 1,051 | 0 |
| Mar 2016 | 0 | 1,002 | 0 |
| Apr 2016 | 0 | 998 | 0 |
| May 2016 | 0 | 1,045 | 0 |
| Jun 2016 | 0 | 1,230 | 0 |
| Jul 2016 | 0 | 1,619 | 0 |
| Aug 2016 | 0 | 1,729 | 0 |
| Sep 2016 | 0 | 1,785 | 0 |
| Oct 2016 | 0 | 1,220 | 0 |
| Nov 2016 | 0 | 1,092 | 0 |
| Dec 2016 | 0 | 1,211 | 0 |
| Jan 2017 | 0 | 1,660 | 0 |
| Feb 2017 | 0 | 1,988 | 0 |
| Mar 2017 | 0 | 2,078 | 0 |
| Apr 2017 | 0 | 2,133 | 0 |
| May 2017 | 0 | 2,370 | 0 |
| Jun 2017 | 0 | 2,194 | 0 |
| Jul 2017 | 0 | 2,183 | 0 |
| Aug 2017 | 0 | 2,466 | 0 |
| Sep 2017 | 1 | 2,189 | 0.46 |
| Oct 2017 | 0 | 3,042 | 0 |
| Nov 2017 | 0 | 1,976 | 0 |
| Dec 2017 | 0 | 2,112 | 0 |
| Jan 2018 | 0 | 2,620 | 0 |
| Feb 2018 | 0 | 2,155 | 0 |
| Mar 2018 | 0 | 2,613 | 0 |
| Apr 2018 | 0 | 2,251 | 0 |
| May 2018 | 0 | 2,828 | 0 |
| Jun 2018 | 0 | 3,871 | 0 |
| Jul 2018 | 0 | 3,067 | 0 |
| Aug 2018 | 0 | 3,757 | 0 |
| Sep 2018 | 0 | 3,512 | 0 |
| Oct 2018 | 0 | 3,261 | 0 |
| Nov 2018 | 0 | 2,861 | 0 |
| Dec 2018 | 0 | 2,754 | 0 |
| Jan 2019 | 0 | 3,672 | 0 |
| Feb 2019 | 0 | 2,715 | 0 |
| Mar 2019 | 0 | 3,317 | 0 |
| Apr 2019 | 0 | 3,141 | 0 |
| May 2019 | 0 | 3,855 | 0 |
| Jun 2019 | 0 | 3,392 | 0 |
| Jul 2019 | 0 | 3,312 | 0 |
| Aug 2019 | 0 | 3,943 | 0 |
| Sep 2019 | 1 | 4,035 | 0.25 |
| Oct 2019 | 0 | 3,922 | 0 |
| Nov 2019 | 0 | 3,508 | 0 |
| Dec 2019 | 0 | 3,659 | 0 |
| Jan 2020 | 0 | 4,650 | 0 |
| Feb 2020 | 0 | 4,374 | 0 |
| Mar 2020 | 0 | 4,475 | 0 |
| Apr 2020 | 0 | 3,690 | 0 |
| May 2020 | 0 | 4,543 | 0 |
| Jun 2020 | 0 | 5,701 | 0 |
| Jul 2020 | 0 | 6,104 | 0 |
| Aug 2020 | 0 | 10,333 | 0 |
| Sep 2020 | 0 | 11,958 | 0 |
| Oct 2020 | 0 | 14,568 | 0 |
| Nov 2020 | 0 | 16,546 | 0 |
| Dec 2020 | 0 | 20,764 | 0 |
| Jan 2021 | 0 | 24,562 | 0 |
| Feb 2021 | 0 | 24,672 | 0 |
| Mar 2021 | 0 | 29,476 | 0 |
| Apr 2021 | 0 | 28,509 | 0 |
| May 2021 | 0 | 25,791 | 0 |
| Jun 2021 | 0 | 27,871 | 0 |
| Jul 2021 | 0 | 27,220 | 0 |
| Aug 2021 | 0 | 30,808 | 0 |
| Sep 2021 | 0 | 30,074 | 0 |
| Oct 2021 | 0 | 22,132 | 0 |
| Nov 2021 | 0 | 27,722 | 0 |
| Dec 2021 | 0 | 31,872 | 0 |
| Jan 2022 | 1 | 42,317 | 0.02 |
| Feb 2022 | 0 | 38,697 | 0 |
| Mar 2022 | 0 | 44,305 | 0 |
| Apr 2022 | 0 | 44,333 | 0 |
| May 2022 | 0 | 50,594 | 0 |
| Jun 2022 | 0 | 49,058 | 0 |
| Jul 2022 | 1 | 53,485 | 0.02 |
| Aug 2022 | 0 | 54,455 | 0 |
| Sep 2022 | 0 | 56,936 | 0 |
| Oct 2022 | 2 | 58,511 | 0.03 |
| Nov 2022 | 0 | 59,198 | 0 |
| Dec 2022 | 0 | 61,576 | 0 |
| Jan 2023 | 1 | 61,004 | 0.02 |
| Feb 2023 | 0 | 50,133 | 0 |
| Mar 2023 | 0 | 59,925 | 0 |
| Apr 2023 | 0 | 54,251 | 0 |
| May 2023 | 0 | 57,768 | 0 |
| Jun 2023 | 1 | 52,679 | 0.02 |
| Jul 2023 | 0 | 56,401 | 0 |
| Aug 2023 | 2 | 65,435 | 0.03 |
| Sep 2023 | 5 | 61,835 | 0.08 |
| Oct 2023 | 2 | 58,419 | 0.03 |
| Nov 2023 | 2 | 53,662 | 0.04 |
| Dec 2023 | 5 | 60,643 | 0.08 |
| Jan 2024 | 0 | 71,818 | 0 |
| Feb 2024 | 0 | 70,045 | 0 |
| Mar 2024 | 0 | 68,261 | 0 |
| Apr 2024 | 0 | 64,374 | 0 |
| May 2024 | 1 | 67,698 | 0.01 |
| Jun 2024 | 1 | 64,720 | 0.02 |
| Jul 2024 | 2 | 65,335 | 0.03 |
| Aug 2024 | 4 | 68,517 | 0.06 |
| Sep 2024 | 1 | 70,168 | 0.01 |
| Oct 2024 | 2 | 72,607 | 0.03 |
| Nov 2024 | 2 | 71,802 | 0.03 |
| Dec 2024 | 5 | 74,401 | 0.07 |
| Jan 2025 | 2 | 77,909 | 0.03 |
| Feb 2025 | 0 | 65,110 | 0 |
| Mar 2025 | 0 | 69,905 | 0 |
| Apr 2025 | 2 | 61,606 | 0.03 |
| May 2025 | 3 | 65,733 | 0.05 |
| Jun 2025 | 4 | 60,540 | 0.07 |
| Jul 2025 | 1 | 62,105 | 0.02 |
| Aug 2025 | 4 | 64,578 | 0.06 |
| Sep 2025 | 2 | 61,704 | 0.03 |
| Oct 2025 | 2 | 59,204 | 0.03 |
| Nov 2025 | 1 | 58,944 | 0.02 |
| Dec 2025 | 0 | 62,830 | 0 |
| Jan 2026 | 0 | 63,321 | 0 |
| Feb 2026 | 0 | 53,085 | 0 |
| Mar 2026 | 1 | 59,208 | 0.02 |
| Apr 2026 | 3 | 53,989 | 0.06 |
| May 2026 | 0 | 57,541 | 0 |
| Jun 2026 | 0 | 55,301 | 0 |
| Jul 2026 | 0 | 56,391 | 0 |
| Aug 2026 | 0 | 56,825 | 0 |
| Sep 2026 | 1 | 57,143 | 0.02 |
Forum and Reddit posts, 4,007,898 in all, counted per month. A mention means the post names the treatment, not that the writer took it. All trends
All 16 people who tried it
-
Almost completely bed bound with ME/CFS, now much better on a JAK inhibitor and ursodiol
A resident physician who developed post-viral dysautonomia after a 2021 upper respiratory infection, later meeting criteria for ME/CFS and POTS. Plasmapheresis and SCIG helped, but stopping PLEX in 2022 triggered a crash and a year-long decline to almost…
-
Long COVID with tremor and insomnia, now nearly back to normal on LDN and rapamycin
He developed long COVID after a COVID infection in June 2022, with neck weakness, a Parkinson-like tremor, severe insomnia, high heart rate, brain fog and eye changes. LDN, Rapamycin and baricitinib each helped, but he was not fully cured. He had COVID twice…
-
Mbajda on Phoenix Rising
Mbajda fell ill in college over 25 years ago, partly recovered, then had two further blows, the worst after a toxic exposure that left him unable to get off the floor for months. Prolonged water and dry fasts did nothing. After a year on tofacitinib and then…
-
Nearly bedbound with ME/CFS for a year, now much better after prednisone and rest
They became ill with ME/CFS after long COVID in early 2022 and were nearly bedbound for about 12 months before improving to mild. Infections in early 2025 and rheumatoid arthritis dropped them to moderate; low-dose prednisone then brought near recovery, and…
-
Severe migraines with long COVID for over two years, much better after Rinvoq and Zyrtec
Wave 19778 had severe migraines and more than two rough years after two Covid infections. Switching from Xeljanz to Rinvoq gave back part of their life, and when feeling better they can do more walking and swimming. Generic Zyrtec reduced migraines to mild…
-
Progressively disabled by ME/CFS over 16 years, improved on Xeljanz then relapsed
ME/CFS had made them progressively more disabled over 16 years, with POTS, hypothyroidism, refractory migraine and overactive bladder. Xeljanz improved their insomnia, exhaustion and bladder within a week, but the benefit faded after about 6.5 months, and a…
-
impossible on Phoenix Rising
impossible fell ill at 13 after dental amalgams and spent years as a hard-case ME/CFS patient with severe gut infections, brain fog and later MCAS. Mould avoidance and cholestyramine brought a big improvement in 2014, clearing his orthostatic intolerance,…
-
ME/CFS mild then moderate; biologics and POTS drugs gave no benefit
A woman with POTS, ulcerative colitis and hidradenitis suppurativa developed ME/CFS in January 2024, after flu and Covid followed by a staph-infected HS flare. She was mild in late 2024 and moderate by 2026, with brain fog, PEM, migraines, neuropathy and…
-
Acute psychosis and bed rest with long COVID, now much better with pacing and testosterone
He got long COVID from a December 2023 infection in Canada: AFIB with an 11-second pause, then acute psychosis and two weeks in a psychiatric ward, then a year mostly on bed rest and eight months off work. A 90-day antiviral and steroid protocol lifted him…
-
Long COVID sometimes bedbound, much better after antivirals and apixaban
A Spanish man fell ill after a second AstraZeneca dose in December 2021 and worsened for two years, sometimes bedbound for days. Apixaban with aspirin and high-dose enzymes, then antivirals, cleared his breathlessness, nausea and poor sleep; he credited the…
-
Case study: CFS/ME remission story severe patient (Treeman)
Treeman, in the UK, first became ill with ME/CFS at age 7 and was housebound and unable to work from 2017. Valacyclovir, started 26 years into his current illness, brought slow small gains, as did rest and pacing. High-dose B1 helped for six weeks then…
-
Long COVID with brain fog, POTS and fatigue; tofacitinib gave no improvement
A 21-year-old male powerlifter and athlete developed long COVID a few years before April 2026, with chronic wet cough, brain fog, POTS, palpitations, nausea, dizziness, anxiety and fatigue. He said tofacitinib 10mg had no effect on his symptoms and he…
-
Long COVID with brutal fatigue, malaise and body pain, now about 90% better on baricitinib
A Reddit user with long COVID/ME/CFS reported brutal fatigue, malaise and body pain and had tried dozens of drugs. Saphnello (for lupus) made them feel like a new person, but maraviroc plus pravastatin caused a severe inflammatory flare and rash, calmed by…
-
Very severe and bedbound with ME/CFS, improved on cilostazol then relapsed
After dengue in 2017 he was moderate until 2020, then declined to very severe and bedbound by 2022 despite pacing. A nicotine patch lifted his PEM and light-sound sensitivity within hours but stopped working after about two weeks; cilostazol later worked and…
-
Long COVID with fatigue and PEM, much improved on low-dose naltrexone and nicotine patches
Acorn 72602, a 46-year-old woman, developed long COVID in May 2022 with dysautonomia, cognitive impairment, fatigue and PEM; a March 2023 reinfection added prediabetes and MCAS. Low-dose naltrexone, antihistamines, a low-histamine diet and paced exercise…
-
Bedridden at weekends with ME/CFS, now much better with modafinil and Adderall XR
Dove 49946 dates his chronic fatigue to July 2021, after a stressful day and a stress reaction that felt like his body and brain broke. Modafinil helped five days a week but tolerance left him bedridden at weekends. Adding Adderall XR for the other two days…
The first 7 credit Tofacitinib (Xeljanz) for their improvement; the other 9 tried it without crediting it.
All 7 people who tried it
-
Long COVID with tremor and insomnia, now nearly back to normal on LDN and rapamycin
He developed long COVID after a COVID infection in June 2022, with neck weakness, a Parkinson-like tremor, severe insomnia, high heart rate, brain fog and eye changes. LDN, Rapamycin and baricitinib each helped, but he was not fully cured. He had COVID twice…
-
Severe migraines with long COVID for over two years, much better after Rinvoq and Zyrtec
Wave 19778 had severe migraines and more than two rough years after two Covid infections. Switching from Xeljanz to Rinvoq gave back part of their life, and when feeling better they can do more walking and swimming. Generic Zyrtec reduced migraines to mild…
-
Acute psychosis and bed rest with long COVID, now much better with pacing and testosterone
He got long COVID from a December 2023 infection in Canada: AFIB with an 11-second pause, then acute psychosis and two weeks in a psychiatric ward, then a year mostly on bed rest and eight months off work. A 90-day antiviral and steroid protocol lifted him…
-
Long COVID sometimes bedbound, much better after antivirals and apixaban
A Spanish man fell ill after a second AstraZeneca dose in December 2021 and worsened for two years, sometimes bedbound for days. Apixaban with aspirin and high-dose enzymes, then antivirals, cleared his breathlessness, nausea and poor sleep; he credited the…
-
Long COVID with brain fog, POTS and fatigue; tofacitinib gave no improvement
A 21-year-old male powerlifter and athlete developed long COVID a few years before April 2026, with chronic wet cough, brain fog, POTS, palpitations, nausea, dizziness, anxiety and fatigue. He said tofacitinib 10mg had no effect on his symptoms and he…
-
Long COVID with brutal fatigue, malaise and body pain, now about 90% better on baricitinib
A Reddit user with long COVID/ME/CFS reported brutal fatigue, malaise and body pain and had tried dozens of drugs. Saphnello (for lupus) made them feel like a new person, but maraviroc plus pravastatin caused a severe inflammatory flare and rash, calmed by…
-
Long COVID with fatigue and PEM, much improved on low-dose naltrexone and nicotine patches
Acorn 72602, a 46-year-old woman, developed long COVID in May 2022 with dysautonomia, cognitive impairment, fatigue and PEM; a March 2023 reinfection added prediabetes and MCAS. Low-dose naltrexone, antihistamines, a low-histamine diet and paced exercise…
The first 2 credit Tofacitinib (Xeljanz) for their improvement; the other 5 tried it without crediting it.
All 9 people who tried it
-
Almost completely bed bound with ME/CFS, now much better on a JAK inhibitor and ursodiol
A resident physician who developed post-viral dysautonomia after a 2021 upper respiratory infection, later meeting criteria for ME/CFS and POTS. Plasmapheresis and SCIG helped, but stopping PLEX in 2022 triggered a crash and a year-long decline to almost…
-
Mbajda on Phoenix Rising
Mbajda fell ill in college over 25 years ago, partly recovered, then had two further blows, the worst after a toxic exposure that left him unable to get off the floor for months. Prolonged water and dry fasts did nothing. After a year on tofacitinib and then…
-
Nearly bedbound with ME/CFS for a year, now much better after prednisone and rest
They became ill with ME/CFS after long COVID in early 2022 and were nearly bedbound for about 12 months before improving to mild. Infections in early 2025 and rheumatoid arthritis dropped them to moderate; low-dose prednisone then brought near recovery, and…
-
Progressively disabled by ME/CFS over 16 years, improved on Xeljanz then relapsed
ME/CFS had made them progressively more disabled over 16 years, with POTS, hypothyroidism, refractory migraine and overactive bladder. Xeljanz improved their insomnia, exhaustion and bladder within a week, but the benefit faded after about 6.5 months, and a…
-
impossible on Phoenix Rising
impossible fell ill at 13 after dental amalgams and spent years as a hard-case ME/CFS patient with severe gut infections, brain fog and later MCAS. Mould avoidance and cholestyramine brought a big improvement in 2014, clearing his orthostatic intolerance,…
-
ME/CFS mild then moderate; biologics and POTS drugs gave no benefit
A woman with POTS, ulcerative colitis and hidradenitis suppurativa developed ME/CFS in January 2024, after flu and Covid followed by a staph-infected HS flare. She was mild in late 2024 and moderate by 2026, with brain fog, PEM, migraines, neuropathy and…
-
Case study: CFS/ME remission story severe patient (Treeman)
Treeman, in the UK, first became ill with ME/CFS at age 7 and was housebound and unable to work from 2017. Valacyclovir, started 26 years into his current illness, brought slow small gains, as did rest and pacing. High-dose B1 helped for six weeks then…
-
Very severe and bedbound with ME/CFS, improved on cilostazol then relapsed
After dengue in 2017 he was moderate until 2020, then declined to very severe and bedbound by 2022 despite pacing. A nicotine patch lifted his PEM and light-sound sensitivity within hours but stopped working after about two weeks; cilostazol later worked and…
-
Bedridden at weekends with ME/CFS, now much better with modafinil and Adderall XR
Dove 49946 dates his chronic fatigue to July 2021, after a stressful day and a stress reaction that felt like his body and brain broke. Modafinil helped five days a week but tolerance left him bedridden at weekends. Adding Adderall XR for the other two days…
The first 5 credit Tofacitinib (Xeljanz) for their improvement; the other 4 tried it without crediting it.